Search

everythinglearnresearchcommunity

for

Search:↓

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Renaming frontal fibrosing alopecia to a syndrome could improve diagnosis and treatment.

The study found that males with KFSD had severe skin and eye symptoms, while female carriers had milder symptoms.

Disrupting the FGF5 gene in rabbits leads to longer hair by extending the hair growth phase.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

A genetic marker linked to a type of hair loss was found in most patients studied.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

Frontal fibrosing alopecia can be diagnosed by examining facial areas and treated with specific medications to stop its progression.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting older women, with no known cause and treatments that may help stabilize hair loss.

Dermatologists should carefully choose treatments for FFA to avoid worsening the condition.

Tretinoin cream successfully treated a woman's skin condition called Fox-Fordyce disease.

Younger people are at a higher risk for Fibrosing Alopecia in a Pattern Distribution than previously thought, with common symptoms and possible involvement of mast cells in its development.

A patient had both chronic cutaneous lupus erythematosus and frontal fibrosing alopecia.

Fibroblast and immune cell interactions affect tissue repair and fibrosis.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Frontal fibrosing alopecia mostly affects postmenopausal women, with diagnosis often delayed by 3 years.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Some family members had a condition with both loose hair and unique eye changes, possibly indicating a new type of ectodermal dysplasia.

The document concludes that treatment can improve hair growth and symptoms in Fibrosing Alopecia in a Pattern Distribution.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

A woman with Fox-Fordyce disease had symptom relief using tretinoin cream.